Category Archives: Clinical Cardiology

I recently received a casual text from a first-year cardiology fellow that read: Should I do cath? My immediate instinct was to reply Yes! I had already reached this decision myself through hours of self-reflection on my skills and future potential in the cath lab, mentorship from attendings, reading literature, writing scientific papers, and weighing the pros and cons for my career and family of being an interventional cardiologist Continue reading →

October 18, 2019 A new study published in Clinical Cardiology[1] introduces the North Indian (NORIN) STSegment Elevation Myocardial Infarction (STEMI) Registry and provides preliminary data collected since its start in January of this year. The prospective cohort studys first author, Sameer Arora, M.D., UNC School of Medicine cardiology fellow and preventive medicine resident, says researchers will follow approximately 3,500 patients admitted for STEMI treatment to two government-funded medical centers in New Delhi, India Continue reading →

BROWNS MILLS, NJ: Deborah Heart and Lung Center is now a clinical affiliate of the Cleveland Clinic Heart & Vascular Institute, further elevating cardiovascular care for patients in the region. The Cleveland Clinic heart program is U.S Continue reading →

Evolocumab added to standard care for hypercholesterolemia was well-tolerated in a diverse patient population, a new analysis revealed. Evolocumab and other anti-PCSK9 antibodies reduced adverse cardiovascular outcomes in clinical trials of high-risk patients over less than three years median treatment duration, the authors wrote in their abstract Continue reading →

Digital healthcare is generating enormous volumes of data related to the health status of patients, but the electronic data currently is not used well for clinical research. The current clinical research operating model was developed decades ago, prior to digital healthcare. It grew out of individual study workflows and capturing patient data on forms, making it largely disconnected from routine clinical practice and modern, real-world care delivery systems Continue reading →

Eva Lopatin Dickerman and Andrew Edward Weil were married Oct. 19 at the Paramour Estate, an events space in Los Angeles. Dan Shear, a Universal Life minister and a friend of the couple, officiated, with Cantor Edward Robin participating. Continue reading →

The trial, led by a team from the University of Edinburgh, used the troponin blood test to detect heart attacks, but with separate thresholds for men and women. The study, funded by the British Heart Foundation (BHF), comes as the American College of Cardiology and other organizations are asking how to get more women to specialize in the fieldin part to address these disparities. Continue reading →

MONTREAL, Oct. 22, 2019 /PRNewswire/ - Optina Diagnostics, a world leader in retinal imaging technology and AI with a vision to change mindsets when it comes to brain health and Dr. Continue reading →

Amal Shahwan Jamee,13 Victor Aboyans,1,2,4Julien Magne,1,2,4Pierre Marie Preux,1,2 Philippe Lacroix1,2,51Tropical Neuroepidemiology, Inserm UMR 1094, Limoges, France; 2School of Medicine, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, University of Limoges, Limoges, France; 3Department of Cardiology, Ministry of Health, Palestine; 4Department of Cardiology, Dupuytren University Hospital, Limoges, France; 5Department of Thoracic and Vascular Surgery Vascular Medicine, Dupuytren University Hospital, Limoges, France Correspondence: Amal Shahwan JameeSchool of Medicine, Institute of Neuroepidemiology and Tropical Neurology, University of Limoges, 2 rue du Dr Marcland, Limoges 87025, FranceTel +33754139112Email dr_amal08@yahoo.fr Background: The metabolic syndrome (MetS) is a major public health and clinical challenge worldwide. However, limited data are available in the Gaza strip. This study was undertaken to evaluate the prevalence of MetS and its association with atherosclerotic risk factors and cardiovascular diseases among Gazan adults community.Methods: A cross-sectional study was conducted in 2017, among all adults 25 years of age Continue reading →

WHIPPANY, N.J., Oct. 21, 2019 /PRNewswire/ -- Bayer today announced recipients of the inaugural Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, a U.S.-based research grant program created to support clinical research in pulmonary hypertension (PH), with a focus on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The recipients will receive a combined total of $1 million in grants over a two-year period, making the PHAB Awards one of the largest industry-funded grant programs focused on PAH and CTEPH in the U.S. Continue reading →